Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Asthma and Allergy|October 13, 2025
Patients with Higher Exacerbation Burden and Eosinophil Counts are More Likely to Require Multiple Biologics for Asthma ControlAlyson N Brown, Tanawin Nopsopon, Ayobami Akenroye
The Journal of Allergy and Clinical Immunology|January 24, 2025
Targeting alarmins in asthma: From bench to clinicAyobami Akenroye, Joshua A Boyce, Hirohito Kita
The Journal of Allergy and Clinical Immunology. in Practice|January 30, 2023
Incidence of Anti-Drug Antibodies to Monoclonal Antibodies in Asthma: A Systematic Review and Meta-AnalysisMing-Li Chen, Tanawin Nopsopon, Ayobami Akenroye
JAMA Network Open|June 24, 2026
Population-Level Trends in Asthma Exacerbations After Introduction of Respiratory BiologicsYung-Fang Tu, David W Stein, Ayobami Akenroye
Scientific Reports|May 6, 2024
Ratio of plasma IL-13/TNF- ∝ and CXCL10/CCL17 predicts mepolizumab and omalizumab response in asthma better than eosinophil count or immunoglobulin E levelAyobami Akenroye, Tanawin Nopsopon, Jonathan J Hacker, et al.
European Journal of Rheumatology|February 14, 2022
Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time courseAnam Tariq, Ayobami Akenroye, Antoine Azar, et al.
Frontiers in Allergy|August 18, 2025
Advancing equity in allergy and immunology: progress, pitfalls, and the path forwardPhilip Mendez, Ayobami Akenroye, Sharmilee M Nyenhuis, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2024
Race and ethnicity, not just insurance, is associated with biologics initiation in asthma and related conditionsAyobami Akenroye, Christopher Hvisdas, Jessica Stern, et al.
Respiratory Research|December 7, 2023
Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analysesAyobami Akenroye, Tanawin Nopsopon, Laura Cho, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 11, 2023
Pharmacoequity in Allergy-Immunology: Disparities in Access to Medications for Allergic Diseases and Proposed Solutions in the United States and GloballyMartin Maldonado-Puebla, Ayobami Akenroye, John Busby, et al.
Pageof 3